Message from the Commissioner
I am pleased to submit the Food and Drug Administration's (FDA) FY 2005 budget that represents the Agency's resource requirements for the coming year. These resources will support our increasingly critical work to protect and advance the health of Americans, by ensuring the safety and security of food and medical products while promoting innovation so that consumers may rapidly obtain more effective health-care products and information.
This request of $1,844,606,000, which includes budget authority and user fees, focuses on four areas that I will briefly highlight. First, we must meet our cost of living adjustment, because our employees account for most of our expenses. Every day, ourten thousand employees perform critical public health work for over 290 million Americans using their scientific expertise, dedication, and integrity. Second, the request funds the critical work involved with protecting the nation's food supply, developing and obtaining medical product countermeasures that may be needed to respond to a possible terrorist attack, and would enable us to strengthen our safeguards in response to potential incidents of bovine spongiform encephalopathy (BSE), such as the recent event in Washington State. Third, our request supports our medical device program and would be augmented with user fees that the Congress and our industry stakeholders agreed to - along with ambitious performance goals - to speed access and reduce the costs of developing innovative medical devices. Finally, the budget request supports our ongoing move to the new Federal Research Center in White Oak, Maryland, where the General Services Administration is building FDA's modern laboratories and office campus.
In order to meet these priorities as efficiently as possible, FDA has made significant progress in implementing the President's Management Agenda (PMA) and the Department of Health and Human Services' secretarial goal for administrative consolidation. We are continuing to consolidate FDA's administrative services delivery into a new shared services organization that is providing high quality service to our organizations, and re-engineering other support functions through out-sourcing in order to operate as effectively and efficiently as possible. FDA has competed in six support functions, all of which were won by FDA employees, which will save the Agency approximately $3 million annually. All of these administrative efficiencies have resulted in our ability to off-set the above increases by $30 million. Our continuing efforts to improve FDA efficiency will allow us to redirect reform savings to national priority, mission-critical areas including food security, counterterrorism, medical countermeasures, bovine spongiform encephalopathy prevention, and patient safety.
I thank you for your continued support of the FDA in the FY 2005 budget.
Mark B. McClellan, M.D., Ph.D.